结核分枝杆菌MPT64疫苗研究进展
出处
《中国人兽共患病学报》
CAS
CSCD
北大核心
2006年第9期880-881,共2页
Chinese Journal of Zoonoses
基金
重庆市卫生局科研基金(05-2-203)资助项目
参考文献13
-
1OettingerT,Holm A,Haslov K.Characterization of the delayed type hypersensitivity-inducing epitope of MPT64 from Mycobacterium tuberculosis[J].Scand J Immunol,1997,45 (5):499-503. 被引量:1
-
2Roche PW,Winter N,Triccas JA,et al.Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco.smegmatis:purification,immunogenicity and application to skin tests for tuberculosis[J].Clin Exp Immunol,1996,103(2):226-232. 被引量:1
-
3Kamath AT,Feng CG,Macdonald M,et al.Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis[J].Infect Immun,1999,67 (4):1702-1707. 被引量:1
-
4Morris S,Kelley C,Howard C,et al.The imnmnogenicity of single and combination DNA vaccine against tuberculosis[J].Vaccine,2000,18(20):2155-2163. 被引量:1
-
5Silver RF,Wallis RS,Ellner JJ.Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guerin in purified protein derivative (PPD)-positive individuals[J].J Immunol,1995,154(9):4665-4674. 被引量:1
-
6骆旭东,陈全,蒋英,江山,朱道银.结核分枝杆菌Ag85B-MPT64融合基因的构建表达[J].第四军医大学学报,2003,24(12):1088-1090. 被引量:5
-
7Harth G,Lee BY,Horwitz MA.High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets[J].Infect Immun,1997,65(6):2321-2328. 被引量:1
-
8Feng CG,Blanchard TJ,Smith GL,et al.Induction of CD8^+ Tlymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus[J].Immunol Cell Biol,2001,79(6):569-575. 被引量:1
-
9McShane H,Brookes R,Gilbert SC,et al.Enhanced immunogenicity of CD4^+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis[J].Infect Immun,2001,69 (2):681-686. 被引量:1
-
10Kamath AT,Hanke T,Briscoe H,et al.Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity,but not protective efficacy against Mycobacterium tuberculosis[J].Immunol,1999,96(4):511-516. 被引量:1
二级参考文献13
-
1奥斯伯F 金斯顿RE.精编分子生物学实验指南[M].北京:科学出版社,1998.29-108. 被引量:115
-
2Wu Y,Kipps TJ.Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytotoxic T lymphocytes[J].J Immunol,1997,159(12):6037-6043. 被引量:1
-
3Baldwin SL, D'Souza C,Roberts AD,et al.Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis[J].Infect Immun,1998,66(6):2951-2959. 被引量:1
-
4Havlir DV,Wallis RS,Boom WH,et al.Human immune response to Mycobacterium tuberculosis antigens[J].Infect Immun,1991,59(2):665-670. 被引量:1
-
5Ravn P,Demissie A,Eguale T,et al.Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis[J].J Infect Dis,1999,179(3):637-645. 被引量:1
-
6Ulmer JB,Liu MA,Montgomery DL,et al.Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination[J].Vaccine,1997,15(8):792-794. 被引量:1
-
7Morris S,Kelley C,Howard A,et al.The immunogenicity of single and combination DNA vaccines against tuberculosis[J].Vaccine,2000,18(20):2155-2163. 被引量:1
-
8谢正,吴挹芳主编.现代微生物培养基和试剂手册[M].福州:福建科学技术出版社,1994.148-149. 被引量:1
-
9Freidag BL,Melton GB,Collins F,et al. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenge with M.tuberculosis[J].Infect Immun,2000,68(5):2948-2953. 被引量:1
-
10Ciechanover A,Orian A,Schwartz AL.Ubiquitin-mediated proteolysis: biological regulation via destruction[J].Bioeassays,2000,22(5):442-451. 被引量:1
共引文献12
-
1王庆敏,胡振林,周凤娟,殷明,章建程,孙树汉.结核杆菌抗原MPT64基因在大肠杆菌中的表达及纯化[J].第二军医大学学报,2004,25(10):1146-1147. 被引量:1
-
2代雪玲,务孔兴,鲁玲,吴宇明.结核分支杆菌特异蛋白抗原研究进展[J].兵团医学,2010(1):40-43.
-
3李文桂,郭建明,陈雅棠.结核分支杆菌ESAT-6DNA疫苗研究进展[J].热带医学杂志,2005,5(2):255-257. 被引量:1
-
4李文桂,陈雅棠.结核分支杆菌热休克蛋白DNA疫苗研究进展[J].热带病与寄生虫学,2005,3(2):111-114. 被引量:1
-
5李文桂,陈雅棠.结核分枝杆菌Ag85 DNA疫苗研究进展[J].中国人兽共患病杂志,2005,21(8):724-727. 被引量:1
-
6李文桂,陈蕊,陈雅棠.结核分支杆菌MPT64 DNA疫苗研究进展[J].国外医学(临床生物化学与检验学分册),2005,26(8):514-516.
-
7姜秀云,王春凤,王春芳,何昭阳.牛分枝杆菌Ag85B基因的克隆及其在大肠杆菌中的表达[J].中国兽医学报,2006,26(1):51-54. 被引量:1
-
8王金昌,李燕萍.泛素—蛋白酶体途径的生物学功能[J].江西科学,2006,24(2):155-158. 被引量:4
-
9曾莉蓉,李文桂.结核分支杆菌ESAT-6疫苗研究进展[J].国际检验医学杂志,2006,27(8):701-703. 被引量:2
-
10王庆敏,孙树汉,康林.遍在蛋白质-结核MPT64融合基因DNA疫苗的构建及免疫效应[J].第二军医大学学报,2008,29(2):117-121.
-
1徐慧雯,曹建平,郑葵阳,潘伟.寄生虫感染治疗炎症性肠病的研究进展[J].中国寄生虫学与寄生虫病杂志,2017,35(2):173-179. 被引量:4
-
2王燕.结核分枝杆菌的检测及疫苗的研制[J].实用医技杂志,2007,14(32):4418-4420.
-
3靳志栋,何永林,徐蕾,佘茜,张丹,张壮苗,杨春.结核分枝杆菌PPE68基因真核表达质粒的构建及鉴定[J].重庆医科大学学报,2011,36(8):907-910. 被引量:3
-
4曾莉蓉,李文桂.结核分支杆菌ESAT-6疫苗研究进展[J].国际检验医学杂志,2006,27(8):701-703. 被引量:2
-
5邹远妩,周祎,高漫,李王平.54例非结核分枝杆菌感染者对二线抗结核药的耐药分析[J].中华实验和临床感染病杂志(电子版),2014,8(1):36-38. 被引量:5
-
6李文桂,陈雅棠.结核分支杆菌热休克蛋白DNA疫苗研究进展[J].热带病与寄生虫学,2005,3(2):111-114. 被引量:1
-
7李文桂,陈雅棠.结核分枝杆菌Ag85 DNA疫苗研究进展[J].中国人兽共患病杂志,2005,21(8):724-727. 被引量:1
-
8汪海鹏,曹健,张雪莲,于海东.结核病疫苗的研究现状与展望[J].河南预防医学杂志,2006,17(2):110-113.
-
9李肖锋,国泰.口服轮状病毒减毒活疫苗Rotarix的现状及研究进展[J].中国生物制品学杂志,2011,24(4):491-493. 被引量:6
-
10李文桂,陈雅棠.结核分枝杆菌重组痘苗病毒疫苗研究进展[J].地方病通报,2005,20(3):106-108.